Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 6/20 | 0.39 |
| ▸ | CES2 | O00748 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 6/20 | 0.30 |
| ▸ | PPARD | Q03181 | 6/20 | 0.30 |
| ▸ | PPARA | Q07869 | 6/20 | 0.30 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.30 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.30 |
| ▸ | TSHR | P16473 | 4/20 | 0.30 |
| ▸ | TLR2 | O60603 | 2/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | FABP4 | P15090 | 2/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.30 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.30 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9285155 | 0.83 | CES1 (0.36) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL9876606 | 0.76 | CES1 (0.42) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL6160528 | 0.74 | — | — | |
| SCHEMBL7997124 | 0.74 | — | — | |
| SCHEMBL29228605 | 0.73 | — | — | |
| SCHEMBL28278267 | 0.72 | CA1 (0.35) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL9496943 | 0.71 | CES1 (0.37) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL8703093 | 0.68 | CES2 (0.48) | CES1CES2ALDH1A1AKR1B1PPARG | |
| SCHEMBL11341426 | 0.67 | CES1 (0.48) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL28625495 | 0.67 | CES1 (0.33) | CES1CES2ALDH1A1TP53CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106167497-B | Heteroaryl and hybar X analog derivative and application thereof | 浙江大学 | 2018-07-31 | — | — | CN | disclosed |
| CN-106167497-A | Heteroaryl hybar X analog derivative and application thereof | 浙江大学 | 2016-11-30 | — | — | CN | disclosed |
| CN-106030889-A | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same | 三菱化学株式会社 | 2016-10-12 | — | — | CN | disclosed |
| CN-100377006-C | Hydrazone-based charge transport materials | SAMSUNG ELECTRONICS CO LTD (KR) | 2008-03-26 | — | — | CN | disclosed |
| US-7179574-B2 | Hydrazone-based charge transport materials | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2007-02-20 | — | — | US | disclosed |
| EP-1584985-B1 | Hydrazone-based charge transport materials | SAMSUNG ELECTRONICS CO LTD (KR) | 2006-12-06 | — | — | EP | disclosed |
| EP-1584985-A2 | Hydrazone-based charge transport materials | Samsung Electronics Co., Ltd. (KR) | 2005-10-12 | — | — | EP | disclosed |
| US-20050221213-A1 | Hydrazone-based charge transport materials | S-PRINTING SOLUTION CO., LTD. (KR) | 2005-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050221213-A1 | Hydrazone-based charge transport materials | SLC9A1, SLC9B2, SLC9A2 | CES1 2212/4885CES2 1978/4885ALDH1A1 501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.